共 29 条
[1]
P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting
[J].
BLOOD COAGULATION & FIBRINOLYSIS,
2013, 24 (05)
:525-531
Zoheir, Naguib
;
Abd Elhamid, Samah
;
Abulata, Nelly
;
El Sobky, Mehry
;
Khafagy, Doaa
;
Mostafa, Amr
.
[2]
Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays.[J].Argirios E. Tsantes;Ignatios Ikonomidis;Ioannis Papadakis;Stefanos Bonovas;Argiri Gialeraki;Christine Kottaridi;Elias Kyriakou;Styliani Kokori;Panagiota Douramani;Petros Kopterides;Petros Karakitsos;John Lekakis;Violetta Kapsimali.Thrombosis Research.2013,
[3]
The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
[J].
INTERNATIONAL JOURNAL OF CARDIOLOGY,
2013, 168 (02)
:1594-1596
Tousoulis, Dimitris
;
Siasos, Gerasimos
;
Zaromitidou, Marina
;
Oikonomou, Evangelos
;
Maniatis, Konstantinos
;
Kioufis, Stamatios
;
Kokkou, Eleni
;
Papavassiliou, Athanasios G.
;
Stefanadis, Christodoulos
.
[4]
Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.[J].Rakhee Kar;Arvind Meena;Birendra K. Yadav;Rakesh Yadav;Sitanshu Sekhar Kar;Renu Saxena.Platelets.2012, 4
[5]
The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients
[J].
BIOCHEMICAL PHARMACOLOGY,
2012, 83 (07)
:903-908
Namazi, Soha
;
Kojuri, Javad
;
Khalili, Andia
;
Azarpira, Negar
.
[6]
Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19; ABCB1; PON1); Non-compliance; Diet; Smoking; Co-medications (including Proton Pump Inhibitors); and Pre-existent Variability in Platelet Function.[J].Andrew L. Frelinger;Deepak L. Bhatt;Ronald D. Lee;Darcy J. Mulford;Jingtao Wu;Sai Nudurupati;Anu Nigam;Michael Lampa;Julie K. Brooks;Marc R. Barnard;Alan D. Michelson.Journal of the American College of Cardiology.2012,
[7]
Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention.[J].Matthew J. Price;Sarah S. Murray;Dominick J. Angiolillo;Elizabeth Lillie;Erin N. Smith;Rebecca L. Tisch;Nicholas J. Schork;Paul S. Teirstein;Eric J. Topol.Journal of the American College of Cardiology.2012, 22
[8]
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.[J].Jeffrey J.W. Verschuren;Helèn Boden;Judith A.M. Wessels;Bas L. van der Hoeven;Stella Trompet;Bastiaan T. Heijmans;Hein Putter;Henk-Jan Guchelaar;Martin J. Schalij;J. Wouter Jukema.International Journal of Cardiology.2012,
[9]
CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention.[J].George Kassimis;Periklis Davlouros;Ioanna Xanthopoulou;Eleana F. Stavrou;Aglaia Athanassiadou;Dimitrios Alexopoulos.Thrombosis Research.2011, 4
[10]
Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin
[J].
CIRCULATION-CARDIOVASCULAR INTERVENTIONS,
2011, 4 (06)
:585-U98
Jeong, Young-Hoon
;
Tantry, Udaya S.
;
Kim, In-Suk
;
Koh, Jin-Sin
;
Kwon, Tae Jung
;
Park, Yongwhi
;
Hwang, Seok-Jae
;
Bliden, Kevin P.
;
Kwak, Choong Hwan
;
Hwang, Jin-Yong
;
Gurbel, Paul A.
.